Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Mass Screening and Selective Treatment With Dihydroartemisinin-piperaquine Plus Primaquine on Malaria Transmission in High Endemic Area, Belu Regency, Nusa Tenggara Timur Province, Indonesia: a Randomized Cluster Trial

NCT01878357 is registered in ClinicalTrials.gov with Indonesia University as lead sponsor.

NCT NCT01878357
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01878357 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Mass Screening and Selective Treatment With Dihydroartemisinin-piperaquine Plus Primaquine on Malaria Transmission in High Endemic Area, Belu Regency, Nusa Tenggara Timur Province, Indonesia: a Randomized Cluster Trial
Lead sponsor
Indonesia University
Phase
Phase 4
Overall status
Completed
Start date
June 30, 2013
Completion date
November 30, 2013
Enrollment
1,488 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

malaria